rs199476128

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4BP6BS2

The ENST00000361624.2(MT-CO1):​c.577G>A​(p.Val193Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 8/11 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V193A) has been classified as Uncertain significance.

Frequency

Mitomap GenBank:
𝑓 0.0026 ( AC: 156 )

Consequence

MT-CO1
ENST00000361624.2 missense

Scores

Apogee2
Benign
0.0072

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:1
Prostate-Cancer-/-enriched-in-POAG-cohort

Conservation

PhyloP100: 3.23

Publications

20 publications found
Variant links:
Genes affected
MT-CO1 (HGNC:7419): (mitochondrially encoded cytochrome c oxidase I) Contributes to cytochrome-c oxidase activity. Predicted to be involved in electron transport coupled proton transport and mitochondrial electron transport, cytochrome c to oxygen. Part of mitochondrial respiratory chain complex III and mitochondrial respiratory chain complex IV. [provided by Alliance of Genome Resources, Apr 2022]
MT-CO1 Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: Mitochondrial Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary recurrent myoglobinuria
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cytochrome-c oxidase deficiency disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • MELAS syndrome
    Inheritance: Mitochondrial Classification: SUPPORTIVE Submitted by: Orphanet
  • mitochondrial non-syndromic sensorineural hearing loss
    Inheritance: Mitochondrial Classification: SUPPORTIVE Submitted by: Orphanet
  • Leigh syndrome
    Inheritance: Mitochondrial Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Apogee2 supports a benign effect, 0.0071823313 < 0.5 .
BP6
Variant M-6480-G-A is Benign according to our data. Variant chrM-6480-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 9666.
BS2
High AC in GnomadMitoHomoplasmic at 183

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COX1unassigned_transcript_4799 c.577G>A p.Val193Ile missense_variant Exon 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MT-CO1ENST00000361624.2 linkc.577G>A p.Val193Ile missense_variant Exon 1 of 1 6 ENSP00000354499.2

Frequencies

Mitomap GenBank
AF:
0.0026
AC:
156
Gnomad homoplasmic
AF:
0.0032
AC:
183
AN:
56425
Gnomad heteroplasmic
AF:
0.00012
AC:
7
AN:
56425
Alfa
AF:
0.00325
Hom.:
150

Mitomap

Disease(s): Prostate-Cancer-/-enriched-in-POAG-cohort
Status: Reported
Publication(s): 15647368

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Mitochondrial complex IV deficiency, nuclear type 1 Pathogenic:1
Nov 01, 1998
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Mitochondrial disease Uncertain:1
Jan 18, 2019
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The MT-COX1 m.6480G>A p.(Val193Ile) missense has been identified in individuals with a phenotype consistent with primary mitochondrial disease (Jaksch et al. 1998a; Jaksch et al. 1998b; Puomila et al. 2007; Cai et al. 2008). In several individuals, a second mitochondrial variant was also identified. The variant has also been reported in two of at least 851 controls, including in one individual who was homoplasmic (Jaksch et al. 1998a; Jaksch et al. 1998b; Cai et al. 2008; Dobrowolski et al. 2009; Ray et al. 2009). Based on the available evidence, the m.6480G>A variant is classified as a variant of uncertain significance for primary mitochondrial disease. -

Leigh syndrome Benign:1
Oct 17, 2019
Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The NC_012920.1:m.6480G>A (YP_003024028.1:p.Val193Ile) variant in MTCO1 gene is interpretated to be a Benign variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes: BS1, BS4, BP4 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
Apogee2
Benign
0.0072
Hmtvar
Benign
0.11
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.61
T
DEOGEN2
Benign
0.011
T
LIST_S2
Benign
0.67
T
MutationAssessor
Benign
-0.68
N
PhyloP100
3.2
PROVEAN
Benign
0.35
N
Sift4G
Benign
1.0
T
GERP RS
4.5
Varity_R
0.22
Mutation Taster
=53/47
polymorphism

Publications

Other links and lift over

dbSNP: rs199476128; hg19: chrM-6481; API